Pregnancy in patients with mucopolysaccharidosis: a case series

Pregnancy in patients with mucopolysaccharidosis: a case series

The mucopolysaccharidoses (MPS disorders) are rare inherited diseases associated with multi-organ accumulation of glycosaminoglycans, leading to musculoskeletal, respiratory, cardiac, neurological, ophthalmological, otolaryngological, and gastrointestinal abnormalities. As a result of improvements i...

Full description

Bibliographic Details
Main Authors:	Fiona J. Stewart, Andrew Bentley, Barbara K. Burton, Nathalie Guffon, Susan L. Hale, Paul R. Harmatz, Susanne G. Kircher, Pavan K. Kochhar, John J. Mitchell, Ursula Plöckinger, Sue Graham, Stephen Sande, Zlatko Sisic, Tracey A. Johnston
Format:	Article
Language:	English
Published:	Elsevier 2016-09-01
Series:	Molecular Genetics and Metabolism Reports
Subjects:	Elosulfase alfa Enzyme replacement therapy Mucopolysaccharidoses Pregnancy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214426916300635

Similar Items

Elosulfase alfa in the treatment of mucopolysaccharidosis type IVA: insights from the first managed access agreement
by: Bob Stevens, et al.
Published: (2021-09-01)

Role of elosulfase alfa in mucopolysaccharidosis IVA
by: Regier DS, et al.
Published: (2016-06-01)

Efficacy of Intravenous Elosulfase Alfa for Mucopolysaccharidosis Type IVA: A Systematic Review and Meta-Analysis
by: Chung-Lin Lee, et al.
Published: (2022-08-01)

Clinical features and health-related quality of life in adult patients with mucopolysaccharidosis IVA: the Spanish experience
by: Pilar Quijada-Fraile, et al.
Published: (2021-11-01)

Airway Abnormalities in Adult Mucopolysaccharidosis and Development of Salford Mucopolysaccharidosis Airway Score
by: Chaitanya Gadepalli, et al.
Published: (2021-07-01)

Clinical characteristics and effects of enzyme replacement therapy with elosulfase alfa in Korean patients with mucopolysaccharidosis type IVA
by: Seung Hoon Lee, et al.
Published: (2022-06-01)

Consensus statement on enzyme replacement therapy for mucopolysaccharidosis IVA in Central and South-Eastern European countries
by: Martin Magner, et al.
Published: (2022-05-01)

Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance
by: Mehmet Umut Akyol, et al.
Published: (2019-06-01)

Impact of long-term elosulfase alfa treatment on clinical and patient-reported outcomes in patients with mucopolysaccharidosis type IVA: results from a Managed Access Agreement in England
by: Maureen Cleary, et al.
Published: (2021-01-01)

Analysis of salivary parameters of mucopolysaccharidosis individuals
by: Patrícia Luciana Serra NUNES, et al.
Published: (2022-01-01)

Safety and Efficacy of Elosulfase Alfa in Australian Patients with Morquio a Syndrome: A Phase 3b Study
by: Kaustuv Bhattacharya, et al.
Published: (2020-05-01)

Salivary Metabolites in Patients with Mucopolysaccharidosis
by: Rafaela de Oliveira Torres, et al.
Published: (2023-11-01)

Features and behavior of valvular abnormalities in adolescent and adult patients in mucopolysaccharidosis: an echocardiographic study
by: Domenico Galzerano, et al.
Published: (2021-08-01)

Once in a Blue Moon, a Very Rare Coexistence of Glutaric Acidemia Type I and Mucopolysaccharidosis Type IIIB in a Patient
by: Mohammad Reza Alaei, et al.
Published: (2020-05-01)

Enzyme-Loaded Gel Core Nanostructured Lipid Carriers to Improve Treatment of Lysosomal Storage Diseases: Formulation and In Vitro Cellular Studies of Elosulfase Alfa-Loaded Systems
by: J. Víctor Álvarez, et al.
Published: (2019-10-01)

Newborn Screening for Mucopolysaccharidosis I: Moving Forward Learning from Experience
by: Lorne A. Clarke, et al.
Published: (2020-11-01)

Biochemical diagnosis of mucopolysaccharidosis in a Mexican reference center
by: Sandra del Carmen Mendoza-Ruvalcaba, et al.
Published: (2020-02-01)

Cardiovascular findings and effects of enzyme replacement therapy in patients with mucopolysaccharidosis type VI
by: Emine Azak, et al.
Published: (2019-10-01)

Expression of Long Noncoding RNAs in Fibroblasts from Mucopolysaccharidosis Patients
by: Zuzanna Cyske, et al.
Published: (2023-01-01)

Clinical and biochemical experience of mucopolysaccharidosis in Cartagena de Indias. Colombia
by: Alvear-Sedan Ciro César, et al.
Published: (2013-06-01)

Evaluation of Cardiovascular Involvement and Cytokine Levels in Patients with Mucopolysaccharidosis
by: Ebru Canda, et al.
Published: (2019-06-01)

Elosulfase alfa enzyme replacement therapy attenuates disease progression in a non-ambulatory Japanese patient with Morquio A syndrome (case report)
by: Misako Hiramatsu, et al.
Published: (2017-12-01)

Sex Difference Leads to Differential Gene Expression Patterns and Therapeutic Efficacy in Mucopolysaccharidosis IVA Murine Model Receiving AAV8 Gene Therapy
by: Matthew Piechnik, et al.
Published: (2022-10-01)

Mucopolysaccharidoses type IV A (Morquio syndrome): A case series of three siblings
by: P Rekka, et al.
Published: (2012-01-01)

Psychobehavioral factors and family functioning in mucopolysaccharidosis: preliminary studies
by: Daniel Almeida do Valle, et al.
Published: (2024-01-01)

Clinical outcomes of laminoplasty for patients with lysosomal storage disease including mucopolysaccharidosis and mucolipidoses: a retrospective cohort study
by: Hidetomi Terai, et al.
Published: (2021-09-01)

Ameloblastoma in a Three-Year-Old Child with Hurler Syndrome (Mucopolysaccharidosis Type I)
by: Mattia Di Bartolomeo, et al.
Published: (2022-03-01)

GENE THERAPY IN MUCOPOLYSACCHARIDOSIS TYPE IIIA: CASE REPORTS
by: Benjamin Lah, et al.
Published: (2022-05-01)

Cervical spine involvement in pediatric mucopolysaccharidosis patients: Clinical features, early diagnosis, and surgical management
by: Hai-Tao Liu, et al.
Published: (2023-01-01)

Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III
by: Arunabha Ghosh, et al.
Published: (2017-06-01)

Understanding the challenges, unmet needs, and expectations of mucopolysaccharidoses I, II and VI patients and their caregivers in France: a survey study
by: Nathalie Guffon, et al.
Published: (2022-12-01)

Mucopolysaccharidosis Type I in Children, a Forgotten Diagnosis Responsible for Undiagnosed Musculoskeletal Complaints: Report of Two Cases
by: Soheila Hoseinzadeh Moghadam, et al.
Published: (2020-02-01)

Assessment of Activity of Daily Life in Mucopolysaccharidosis Type II Patients with Hematopoietic Stem Cell Transplantation
by: Yasuyuki Suzuki, et al.
Published: (2020-01-01)

Clinical and Radiological Characterisation of Patients with Mucopolysaccharidosis in a Genetic Clinic
by: Pallavelangini Swetha, et al.
Published: (2021-03-01)

Long-Term Follow-up Posthematopoietic Stem Cell Transplantation in a Japanese Patient with Type-VII Mucopolysaccharidosis
by: Kenji Orii, et al.
Published: (2020-02-01)

Diagnostics of mucopolysaccharidoses presented through the case of sanfilippo syndrome
by: Durković Jasmina
Published: (2004-01-01)

Consequências da judicialização das políticas de saúde: custos de medicamentos para as mucopolissacaridoses Consequences of the judicialization of health policies: the cost of medicines for mucopolysaccharidosis
by: Debora Diniz, et al.
Published: (2012-03-01)

Mucopolysaccharidosis
by: Kusumitha Bhakthaganesh, et al.
Published: (2023-01-01)

Atypical corneal clouding in mucopolysaccharidoses
by: Mary Stephen, et al.
Published: (2023-01-01)

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Different Donors in Recipients With Mucopolysaccharidosis
by: Yuhua Qu, et al.
Published: (2022-06-01)